Ionis Pharmaceuticals (IONS, $41.97) was a top loser over the last three months, falling -1 to $41.97 per share. A.I.dvisor analyzed 912 stocks in the Biotechnology Industry for the 3-month period ending May 3, 2024, and found that of them (5) exhibited an Uptrend while of them (4) demonstrated a Downtrend.